BioRels’ data infrastructure: a scientific schema and exchange standard to transform and enhance biological data sciences
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Jibo Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lilly Genetic Medicines, Eli Lilly and Company, Indianapolis, IN 46285, United States. Hauptthemen laut MEDLINE: Software, Data Science, Databases, Factual. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Our understanding of biology and medicinal sciences augmented by advances in data structures and algorithms has resulted in proliferation of thousands of open-sourced resources, tools, and websites that are made by the scientific community to access, process, store, and visualize biological data. However, such data have become increasingly complex and heterogeneous, leading to an entangled web of relationships and external identifiers. Despite emergence of infrastructure such as data lakes, the scientists are still responsible for the time consuming and costly exercise to find, extract, clean, prepare, and maintain such data sources while following the FAIR principles. To better understand the complexity, we lay down a representation of the mainstream data ecosystem, describing the natural relationships and concepts found in biology. Built upon it and the fundamental principles of data unicity and atomicity, we introduce BioRels, an automated and standardized data preparation workstream aiming at improving reproducibility and speed for all scientists and handling up to 145 billion data points. BioRels allows complex querying capabilities across several data sources seamlessly and provides an exchange format, BIORJ, to export and import data with all its dependency and metadata. At last, we describe the advantages, limitations, applications, and perspectives of a future approach BioRels-KB to expand future data preparation capabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lilly Genetic Medicines, Eli Lilly and Company, Indianapolis, IN 46285, United States.
- Research-IDS, Eli Lilly and Company, Indianapolis, IN 46285, United States.
- Tech@Lilly, Eli Lilly and Company, Indianapolis, IN 46285, United States.
ORCID-Profile: Lauren Murray, Bruno Dos Santos, Jeremy Desaphy
Förderung
- Eli Lilly and Company
Zitieren
APA
Wang, J., Turney, A., Murray, L., Craven, A. M., Bragger-Wilkinson, P., Dos Santos, B., Martasek, J., & Desaphy, J. (2025). BioRels’ data infrastructure: a scientific schema and exchange standard to transform and enhance biological data sciences. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf254
Vancouver
Wang J, Turney A, Murray L, Craven AM, Bragger-Wilkinson P, Dos Santos B, et al. BioRels’ data infrastructure: a scientific schema and exchange standard to transform and enhance biological data sciences. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf254
BibTeX
@article{Wang2025,
author = {Wang, Jibo and Turney, Amanda and Murray, Lauren and Craven, Andrew M and Bragger-Wilkinson, Patty and Dos Santos, Bruno and Martasek, Jaroslav and Desaphy, Jeremy},
title = {BioRels’ data infrastructure: a scientific schema and exchange standard to transform and enhance biological data sciences},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf254}
}
EUVIMED